Bağırsak Mikrobiyotası ve Diyabet

Pelzer, E., Gomez-Arango, L. F., Barrett, H. L., & Nitert, M. D. (2017). Maternal health and the placental microbiome. Placenta, 54, 30-37.

Power, S. E., O'Toole, P. W., Stanton, C., Ross, R. P., & Fitzgerald, G. F. (2014). Intestinal microbiota, diet and health. British Journal of Nutrition, 111(3), 387-402.

Yang, N. J., & Chiu, I. M. (2017). Bacterial signaling to the nervous system through toxins and metabolites. Journal of molecular biology, 429(5), 587-605.

Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., ... & Raes, J. (2016). Population-level analysis of gut microbiome variation. Science, 352(6285), 560-564.

Sommer, F., & Bäckhed, F. (2016). Know your neighbor: Microbiota and host epithelial cells interact locally to control intestinal function and physiology. BioEssays, 38(5), 455-464.

Sonnenburg, J., & Sonnenburg, E. (2015). Gut feelings—The “second brain” in our gastrointestinal systems. Scientific American, 313(3), 24-27.

von Martels, J. Z., Sadabad, M. S., Bourgonje, A. R., Blokzijl, T., Dijkstra, G., Faber, K. N., & Harmsen, H. J. (2017). The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut. Anaerobe, 44, 3-12.

Pagliari D, et al. The Interactions between Innate Immunity and Microbiota in Gastrointestinal Diseases. J Immunol Res 2015;2015:1-3

Liu, S. (2016). The development of our organ of other kinds—The gut microbiota. Frontiers in Microbiology, 7, 240167.

Martin, F. P. J., Montoliu, I., & Kussmann, M. (2017). Metabonomics of ageing–towards understanding metabolism of a long and healthy life. Mechanisms of ageing and development, 165, 171-179.

von Martels, J. Z., Sadabad, M. S., Bourgonje, A. R., Blokzijl, T., Dijkstra, G., Faber, K. N., & Harmsen, H. J. (2017). The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut. Anaerobe, 44, 3-12.

13.Ochoa-Repáraz J, Kasper L H. The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Curr Obes Rep 2016;5(1):51-64

Yao, J., & Rock, C. O. (2015). How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics. Journal of Biological Chemistry, 290(10), 5940-5946.

Burcelin, R., Serino, M., Chabo, C., Blasco-Baque, V., & Amar, J. (2011). Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta diabetologica, 48, 257-273.

Cardwell, C. R., Stene, L. C., Joner, G., Cinek, O., Svensson, J., Goldacre, M. J., ... & Patterson, C. C. (2008). Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia, 51, 726-735.

Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., ... & Triplett, E. W. (2011). Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PloS one, 6(10), e25792.

Han, J. L., & Lin, H. L. (2014). Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. World journal of gastroenterology: WJG, 20(47), 17737.

Pokrzywnicka, P., & Gumprecht, J. (2016). Intestinal microbiota and its relationship with diabetes and obesity. Clinical Diabetology, 5(5), 164-172.

Ostrowska, L. O. L., Marlicz, W., & Łoniewski, I. (2013). Transplantacja mikroflory jelitowej w leczeniu otyłości i zaburzeń metabolicznych—metoda nadal ryzykowna i niepotwierdzona wynikami badań klinicznych. In Forum Zaburzeń Metabolicznych (Vol. 4, No. 4, pp. 161-169).

Pelzer, E., Gomez-Arango, L. F., Barrett, H. L., & Nitert, M. D. (2017). Maternal health and the placental microbiome. Placenta, 54, 30-37.

Power, S. E., O'Toole, P. W., Stanton, C., Ross, R. P., & Fitzgerald, G. F. (2014). Intestinal microbiota, diet and health. British Journal of Nutrition, 111(3), 387-402.

Yang, N. J., & Chiu, I. M. (2017). Bacterial signaling to the nervous system through toxins and metabolites. Journal of molecular biology, 429(5), 587-605.

Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., ... & Raes, J. (2016). Population-level analysis of gut microbiome variation. Science, 352(6285), 560-564.

Sommer, F., & Bäckhed, F. (2016). Know your neighbor: Microbiota and host epithelial cells interact locally to control intestinal function and physiology. BioEssays, 38(5), 455-464.

Sonnenburg, J., & Sonnenburg, E. (2015). Gut feelings—The “second brain” in our gastrointestinal systems. Scientific American, 313(3), 24-27.

von Martels, J. Z., Sadabad, M. S., Bourgonje, A. R., Blokzijl, T., Dijkstra, G., Faber, K. N., & Harmsen, H. J. (2017). The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut. Anaerobe, 44, 3-12.

Pagliari D, et al. The Interactions between Innate Immunity and Microbiota in Gastrointestinal Diseases. J Immunol Res 2015;2015:1-3

Liu, S. (2016). The development of our organ of other kinds—The gut microbiota. Frontiers in Microbiology, 7, 240167.

Martin, F. P. J., Montoliu, I., & Kussmann, M. (2017). Metabonomics of ageing–towards understanding metabolism of a long and healthy life. Mechanisms of ageing and development, 165, 171-179.

von Martels, J. Z., Sadabad, M. S., Bourgonje, A. R., Blokzijl, T., Dijkstra, G., Faber, K. N., & Harmsen, H. J. (2017). The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut. Anaerobe, 44, 3-12.

13.Ochoa-Repáraz J, Kasper L H. The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Curr Obes Rep 2016;5(1):51-64

Yao, J., & Rock, C. O. (2015). How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics. Journal of Biological Chemistry, 290(10), 5940-5946.

Burcelin, R., Serino, M., Chabo, C., Blasco-Baque, V., & Amar, J. (2011). Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta diabetologica, 48, 257-273.

Cardwell, C. R., Stene, L. C., Joner, G., Cinek, O., Svensson, J., Goldacre, M. J., ... & Patterson, C. C. (2008). Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia, 51, 726-735.

Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., ... & Triplett, E. W. (2011). Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PloS one, 6(10), e25792.

Han, J. L., & Lin, H. L. (2014). Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. World journal of gastroenterology: WJG, 20(47), 17737.

Pokrzywnicka, P., & Gumprecht, J. (2016). Intestinal microbiota and its relationship with diabetes and obesity. Clinical Diabetology, 5(5), 164-172.

Ostrowska, L. O. L., Marlicz, W., & Łoniewski, I. (2013). Transplantacja mikroflory jelitowej w leczeniu otyłości i zaburzeń metabolicznych—metoda nadal ryzykowna i niepotwierdzona wynikami badań klinicznych. In Forum Zaburzeń Metabolicznych (Vol. 4, No. 4, pp. 161-169).